Skip to content

The Efficacy of Extra- Versus Intrafascial Injection for Supraclavicular Brachial Plexus Block

The Efficacy of Extra- Versus Intrafascial Injection for Supraclavicular Brachial Plexus Block: a Randomized Controlled, Single-blinded Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03957772
Acronym
SUPRA
Enrollment
50
Registered
2019-05-21
Start date
2020-01-01
Completion date
2021-04-30
Last updated
2021-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Extremity Problem

Keywords

upper extremity surgery

Brief summary

Patients will be randomized to one of two groups: 1. Extrafascial injection group: Ultrasound-guided supraclavicular brachial plexus block with 2 injections of local anaesthetic, deposited at the exterior of the fascial sheath that surrounds the nerves 2. Intrafascial injection group: Ultrasound-guided supraclavicular brachial plexus block with 2 injections of local anaesthetic, deposited at the interior of the fascial sheath that surrounds the nerves

Detailed description

The study will be proposed to all patients undergoing formarm or hand surgery under axillary brachial plexus block. Patients will be randomized to one of two groups. The first group - extrafascial injection group - will receive an ultrasound-guided supraclavicular brachial plexus block whereby the local anesthetic will be deposited at the exterior of the fascial sheath that surrounds the nerves. The second group - intrafascial injection group - will receive an ultrasound-guided supraclavicular brachial plexus block whereby the local anesthetic will be deposited at the interior of the fascial sheath that surrounds the nerves. All patients will receive the same type and amount of local anesthetic: 30 ml of a mixture of ropivacaine 0.5 % + mepivacaine 1 %. The primary outcome is the rate of hemidiaphragmatic paresis 30 minutes after the block procedure, assessed with ultrasound. Secondary outcomes are: rate of hemidiaphragmatic paresis 2 hours after surgery, assessed with ultrasound, bedside spirometry before the supraclavicular block, 30 minutes after the block and 2 hours after surgery, rate of successful block 30 minutes after the block , duration of sensory and motor block, pain scores at rest and on movement at 24 h postoperatively, cumulative postoperative opioid consumption at 24 hours postoperatively and patient satisfaction with overall anesthetic management. These outcomes are further defined in the section below.

Interventions

PROCEDUREExtrafascial injection

Extrafascial injection of local anaesthetic under ultrasound guidance

PROCEDUREIntrafascial injection

Intrafascial injection of local anaesthetic under ultrasound guidance

Sponsors

University of Lausanne Hospitals
CollaboratorOTHER
Hôpital du Valais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

The participants and all care providers will be blinded to the patient assignment.

Intervention model description

Parallel assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing forearm or hand surgery under locoregional anesthesia * ASA physical status I-III

Exclusion criteria

* Patient refusal * ASA physical status IV * Severe pre-existing lung disease * Patient unwilling or unable to perform incentive spirometry * Local anesthetic intolerance or allergy * Neurological deficit or neuropathy of the arm * Coagulopathy contraindicating locoregional anesthesia * Malignancy or infection in the area above the clavicle * Pregnancy * Inability to understand the informed consent

Design outcomes

Primary

MeasureTime frameDescription
Hemidiaphragmatic paresis 30 minutes after the block30 minutes after the blockRate of hemidiaphragmatic paresis 30 minutes after the block procedure, assessed with ultrasound

Secondary

MeasureTime frameDescription
Bedside spirometry before the block (baseline)30 minutes before the blockBedside spirometry before the supraclavicular block
Bedside spirometry after 30 minutes after the block30 minutes after the supraclavicular blockBedside spirometry after the supraclavicular block
Bedside spirometry 2 hours after surgery2 hours after surgeryBedside spirometry 2 hours after surgery
Rate of successful block 30 minutes after the block30 minutes after the blockPresence of a surgical block according to a validated composite scale
Hemidiaphragmatic paresis 2 hours after surgery2 hours after surgeryRate of hemidiaphragmatic paresis 2 hours after surgery, assessed with ultrasound
Pain during block procedureDuring block procedurePain score (numeric rating scale, 0-10, with 0=no pain, 10=worst imaginable pain)
Pain at rest and on movement24 h postoperativelyPain score (numeric rating scale, 0-10, with 0=no pain, 10=worst imaginable pain)
Postoperative opioid consumption24 hours postoperativelyCumulative postoperative opioid consumption
Patient satisfaction with overall anesthetic management24 hours postoperativelynumeric rating scale, 0-10)
Block-related side effects24 h postoperativelyparesthesia, dyspnea, Horner's syndrome, hoarseness, hematoma, infection

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026